Is HLNE or HQH more undervalued in 2026?

CirclFi compares Hamilton Lane Incorporated (HLNE) and Tekla Healthcare Investors (HQH) using 13 institutional-grade valuation models. HLNE has a Quality of Company score of 9.7/10 while HQH scores 1.8/10.

Which is a better buy — HLNE or HQH?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do HLNE and HQH valuations compare?

HLNE at $86.15 and HQH at $19.65 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

HLNE vs HQH Valuation Comparison 2026 — Intrinsic Value Analysis

HLNE

Asset Management

Hamilton Lane Incorporated

Quality

9.7

out of 10

Value Trap

SAFE

Price

$86.15

Last close

Models

13/13

Active

HQH

Asset Management

Tekla Healthcare Investors

Quality

1.8

out of 10

Value Trap

—

Price

$19.65

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	HLNE Fair Value	HLNE Upside	HQH Fair Value	HQH Upside
Bayesian DCF	Intrinsic	$95.36	+10.7%	$5.20	-73.5%
Earnings Power Value	Intrinsic	$52.53	-39.0%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$169.80	+97.1%	$22.03	+12.1%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for HLNE vs HQH — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HLNE vs HQH — Which Stock Is More Undervalued?

HLNE scores higher with a 9.7/10 quality rating vs HQH's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Hamilton Lane Incorporated (HLNE) and Tekla Healthcare Investors (HQH) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HLNE currently trades at $86.15 with a QOC of 9.7/10, while HQH trades at $19.65 with a QOC of 1.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).